Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Remodulin (Treprostinil Sodium) Injection
Company:  United Therapeutics Corporation
Application No.:  21-272
Approval Date: 5/21/02


Date created: July 31, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.